Eaton Vance Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,107
Closed -$188K 2450
2021
Q4
$188K Buy
3,107
+65
+2% +$3.86K ﹤0.01% 1586
2021
Q3
$0 Buy
3,042
+82
+3% +$4.5K ﹤0.01% 2503
2021
Q2
$154K Buy
2,960
+2,578
+675% +$124K ﹤0.01% 1717
2021
Q1
$17K Buy
+382
New +$16.1K ﹤0.01% 2154
2015
Q3
Sell
-16,781
Closed -$776K 966
2015
Q2
$776K Sell
16,781
-61,073
-78% -$2.67M ﹤0.01% 670
2015
Q1
$3.34M Sell
77,854
-14,142
-15% -$539K 0.01% 482
2014
Q4
$3.19M Buy
91,996
+8,845
+11% +$294K 0.01% 480
2014
Q3
$2.69M Sell
83,151
-8,266
-9% -$277K 0.01% 485
2014
Q2
$3.1M Buy
+91,417
New +$2.93M 0.01% 471

Other funds holding PBH

Eaton Vance Management's PBH Position: Q1 2022 in Review

Eaton Vance Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2022, closing a stake of 3,107 shares — an estimated $188K sold.

Eaton Vance Management first reported a position in PBH in Q2 2014 and held it in 9 quarters. The position peaked at $3.34M in Q1 2015. 286 funds tracked by Wall St. Rank hold PBH as of Q1 2022.

  • Eaton Vance Management reported no remaining Prestige Consumer Healthcare position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 3,107 Prestige Consumer Healthcare shares in Q1 2022, an estimated $188K.
  • Eaton Vance Management first reported a position in Prestige Consumer Healthcare in Q2 2014 and held it in 9 quarters.
  • Eaton Vance Management's Prestige Consumer Healthcare position peaked at $3.34M in Q1 2015.
  • 286 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.